Cryoport to Report Third Quarter 2026 Financial Results on November 5, 2026PRNewsWire · 2 days ago
Is CryoPort (CYRX) Outperforming Other Medical Stocks This Year?Zacks Investment Research · Oct 1, 2026
Cryoport: Strong Pipeline Of Cell And Gene Therapy ApprovalsSeeking Alpha · Sep 25, 2026
CryoPort (CYRX) Upgraded to Buy: Here's WhyZacks Investment Research · Aug 11, 2026
Cryoport, Inc. (CYRX) Q2 2026 Earnings Call TranscriptSeeking Alpha · Aug 7, 2026
CryoPort Q2 Earnings Call HighlightsMarketBeat · Aug 6, 2026Cryoport, Inc. operates as a specialized service provider within the life sciences sector, delivering global temperature-controlled supply chain solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Central to their offerings is Cryoportal, a proprietary cloud-based platform designed to streamline the entire logistics process. This robust system facilitates order processing, generates necessary documentation (including customs paperwork), coordinates courier services, offers real-time shipment tracking and monitoring, aids in issue resolution, and ensures adherence to regulatory compliance standards.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 6, 2026 | -$0.19 | -$0.20 | Miss |
| May 4, 2026 | -$0.20 | -$0.23 | Miss |
| Mar 3, 2026 | -$0.19 | -$0.21 | Miss |
| Nov 4, 2025 | -$0.23 | -$0.18 | Beat |
| Aug 5, 2025 | -$0.20 | -$0.29 | Miss |
| May 7, 2025 | -$0.23 | -$0.22 | Beat |